Inpharma Weekly

, Volume 1508, Issue 1, pp 3–3

Oseltamivir, zanamivir leading the charge against influenza H5N1

News item

DOI: 10.2165/00128413-200515080-00004

Cite this article as:
Inpharma Wkly. (2005) 1508: 3. doi:10.2165/00128413-200515080-00004
  • 2 Downloads

Copyright information

© Adis International Ltd 2005

Personalised recommendations